English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cutaneous melanoma is the most aggressive form of skin cancer, with a high mortality rate if not treated in a timely manner [1]. Although melanomas are far less common than other cutaneous carcinomas, such as basal cell carcinomas (BCC) or squamous cell carcinomas (SCC), melanomas account for the majority of deaths from skin cancer [2-4]. It is estimated that in 2015 there will be 9,940 deaths from melanoma, and 74,000 new cases of this malignancy [5]. Therefore, careful attention to established risk factors, especially in individuals prone to melanoma development, is important for detecting malignant lesions in their early stages [6,7]. When detected early, melanoma is quite curable the five-year survival rate of Stage 1A melanoma is 91-99% [8]. However, with increasing tumor stage, the survival rate drastically decreases to 65-73% for stage IIIA tumors and 16-22% for stage IV tumors [8]. Thus, early detection and treatment of these malignant neoplasms is crucial to improving the probability of survival.

journal of clinical and investigative dermatology

A Survey of Timeframe Variations for the Management of Early Stage Melanoma among Dermatology Residency and Procedural Dermatology Fellowship Training Programs in the United States